These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28219205)

  • 1. [Preparation of chaperone-antigen peptide vaccine derived from human gastric cancer stem cells and its immune function].
    Jiang YQ; Guo QM; Xu XP; Liang JC; He YY; An SH; Su F; Li CY; Huang CX
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):109-114. PubMed ID: 28219205
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells.
    Enomoto Y; Bharti A; Khaleque AA; Song B; Liu C; Apostolopoulos V; Xing PX; Calderwood SK; Gong J
    J Immunol; 2006 Nov; 177(9):5946-55. PubMed ID: 17056519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods of purification of heat shock protein-peptide complexes for use as vaccines against cancers and infectious diseases.
    Srivastava PK; Jaikaria NS
    Methods Mol Biol; 2001; 156():175-86. PubMed ID: 11068759
    [No Abstract]   [Full Text] [Related]  

  • 4. [Preparation of anticolon carcinoma vaccine with rich chaperone peptides and study on its anticancer efficacy].
    Zhao JG; Huang CX; Yang GG; Jin JF; Kang YP; Xia DJ; Wang QQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):290-3. PubMed ID: 19434541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
    Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
    J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.
    Graner MW; Romanoski A; Katsanis E
    Int J Hyperthermia; 2013 Aug; 29(5):380-9. PubMed ID: 23725202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic-tumor fusion cells derived heat shock protein70-peptide complex has enhanced immunogenicity.
    Zhang Y; Zhang Y; Chen J; Liu Y; Luo W
    PLoS One; 2015; 10(5):e0126075. PubMed ID: 25961716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted immunotherapy using reconstituted chaperone complexes of heat shock protein 110 and melanoma-associated antigen gp100.
    Wang XY; Chen X; Manjili MH; Repasky E; Henderson R; Subjeck JR
    Cancer Res; 2003 May; 63(10):2553-60. PubMed ID: 12750279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
    Wang XY; Sun X; Chen X; Facciponte J; Repasky EA; Kane J; Subjeck JR
    J Immunol; 2010 Jun; 184(11):6309-19. PubMed ID: 20439916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock proteins and heat shock protein-antibody complexes in placental tissues.
    Ziegert M; Witkin SS; Sziller I; Alexander H; Brylla E; Härtig W
    Infect Dis Obstet Gynecol; 1999; 7(4):180-5. PubMed ID: 10449265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Heat Shock Protein 70-based Vaccine Prepared from DC-Tumor Fusion Cells.
    Weng D; Calderwood SK; Gong J
    Methods Mol Biol; 2018; 1709():359-369. PubMed ID: 29177672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of multiple heat shock proteins from a single tumor sample.
    Ménoret A; Bell G
    J Immunol Methods; 2000 Apr; 237(1-2):119-30. PubMed ID: 10725457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purification of heat shock protein 70-associated tumor peptides and their antitumor immunity to hepatoma in mice.
    Chen DX; Su YR; Shao GZ; Qian ZC
    World J Gastroenterol; 2004 Feb; 10(3):361-5. PubMed ID: 14760758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein.
    Quintana FJ; Carmi P; Mor F; Cohen IR
    Arthritis Rheum; 2004 Nov; 50(11):3712-20. PubMed ID: 15529360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.
    Manjili MH; Henderson R; Wang XY; Chen X; Li Y; Repasky E; Kazim L; Subjeck JR
    Cancer Res; 2002 Mar; 62(6):1737-42. PubMed ID: 11912148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use.
    Gong J; Zhang Y; Durfee J; Weng D; Liu C; Koido S; Song B; Apostolopoulos V; Calderwood SK
    J Immunol; 2010 Jan; 184(1):488-96. PubMed ID: 19949080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
    Srivastava PK
    Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy.
    Guo C; Subjeck JR; Wang XY
    Methods Mol Biol; 2018; 1709():345-357. PubMed ID: 29177671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of immunogenic heat shock protein 70-peptide complexes by ADP-affinity chromatography.
    Peng P; Ménoret A; Srivastava PK
    J Immunol Methods; 1997 May; 204(1):13-21. PubMed ID: 9202705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins.
    Wang XY; Manjili MH; Park J; Chen X; Repasky E; Subjeck JR
    Methods; 2004 Jan; 32(1):13-20. PubMed ID: 14624871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.